Boots Urgently Recalls Paracetamol Due to Packaging Error

Boots has issued an urgent recall notice and warned customers not to consume a specific batch of their own-brand paracetamol tablets. The recall has been initiated due to a labelling mistake, with the packaging incorrectly indicating that the tablets inside are aspirin instead of paracetamol.

Although paracetamol and aspirin are both common painkillers available over-the-counter, aspirin can pose risks for individuals with certain health conditions, especially stomach-related complications. As a precaution, Medicines and Healthcare products Regulatory Agency (MHRA) collaborated with Boots to promptly release a recall notice, urging customers to return these products as quickly as possible.

The specific batch affected by the recall is number 241005. Customers are asked to verify this batch number on their Boots 500mg Paracetamol packs and, if they match, to cease using the medication immediately and return the product to any Boots store. Boots has confirmed the tablets inside the packaging are indeed the correct 500mg paracetamol tablets; however, due to potential confusion caused by the mislabelled foil packaging, the recall was deemed necessary.

Dr Stephanie Millican, MHRA Deputy Director for Benefit Risk Evaluation, emphasized the priority placed upon patient safety, advising customers who are uncertain or experiencing any adverse reactions to seek advice immediately from healthcare professionals. She also asked people to report any suspected side effects from the medication through MHRA's Yellow Card scheme and encouraged customers needing further clarifications to contact a pharmacist or medical professional.